Fundz

E Genesis, Inc. reported raising $12.6 Million in an initial SEC Form D filing, from an offering of $38.2 Million

PRIVATEMar 23, 2017$12.6M of $38.2M raised

Amount Raised

$12.6 Million

$12.6 Million sold, per SEC Form D (first sale Mar 23, 2017)

Round Type

Venture

CambridgeBiotechnology

Quick answer

eGenesis raised $12.6 Million in a funding round, dated March 23, 2017. eGenesis is based in Cambridge, Massachusetts, United States.

How much did eGenesis raise?
eGenesis raised $12.6 Million in a funding round on March 23, 2017.
What does eGenesis do?
eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells.
Where is eGenesis based and how big is it?
eGenesis is based in Cambridge, Massachusetts, United States.
Who are the decision-makers at eGenesis?
Fundz holds 1 contact at eGenesis. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as eGenesis that raised within 45 days of this round, from Fundz verified event records.

Who to call at eGenesis, and when

A new round usually means eGenesis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day eGenesis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at eGenesis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at eGenesis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

eGenesis

Location

300 TECHNOLOGY SQUARE

Cambridge, Massachusetts, United States

About

eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis’ mission is to solve the global organ shortage crisis by developing a scalable alternative to allotransplantation. eGenesis is reinvigorating the field of xenotransplantation by addressing the key virology and immunology hurdles that have prevented its advancement to date, and is developing commercially-viable products to save and improve the lives of patients who are waiting for an organ transplant.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment eGenesis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts19 people are listed at eGenesis. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for eGenesis's next move

See what Strategic adds

eGenesis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.